Cargando…

Correction: Reversing Multidrug Resistance in Caco-2 by Silencing MDR1, MRP1, MRP2, and BCL-2/BCL-xL Using Liposomal Antisense Oligonucleotides

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219840/
http://dx.doi.org/10.1371/journal.pone.0112604
_version_ 1782342651988672512
collection PubMed
description
format Online
Article
Text
id pubmed-4219840
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-42198402014-11-12 Correction: Reversing Multidrug Resistance in Caco-2 by Silencing MDR1, MRP1, MRP2, and BCL-2/BCL-xL Using Liposomal Antisense Oligonucleotides PLoS One Correction Public Library of Science 2014-11-04 /pmc/articles/PMC4219840/ http://dx.doi.org/10.1371/journal.pone.0112604 Text en © 2014 The PLOS ONE Staff http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Correction
Correction: Reversing Multidrug Resistance in Caco-2 by Silencing MDR1, MRP1, MRP2, and BCL-2/BCL-xL Using Liposomal Antisense Oligonucleotides
title Correction: Reversing Multidrug Resistance in Caco-2 by Silencing MDR1, MRP1, MRP2, and BCL-2/BCL-xL Using Liposomal Antisense Oligonucleotides
title_full Correction: Reversing Multidrug Resistance in Caco-2 by Silencing MDR1, MRP1, MRP2, and BCL-2/BCL-xL Using Liposomal Antisense Oligonucleotides
title_fullStr Correction: Reversing Multidrug Resistance in Caco-2 by Silencing MDR1, MRP1, MRP2, and BCL-2/BCL-xL Using Liposomal Antisense Oligonucleotides
title_full_unstemmed Correction: Reversing Multidrug Resistance in Caco-2 by Silencing MDR1, MRP1, MRP2, and BCL-2/BCL-xL Using Liposomal Antisense Oligonucleotides
title_short Correction: Reversing Multidrug Resistance in Caco-2 by Silencing MDR1, MRP1, MRP2, and BCL-2/BCL-xL Using Liposomal Antisense Oligonucleotides
title_sort correction: reversing multidrug resistance in caco-2 by silencing mdr1, mrp1, mrp2, and bcl-2/bcl-xl using liposomal antisense oligonucleotides
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219840/
http://dx.doi.org/10.1371/journal.pone.0112604
work_keys_str_mv AT correctionreversingmultidrugresistanceincaco2bysilencingmdr1mrp1mrp2andbcl2bclxlusingliposomalantisenseoligonucleotides